Randomized, double-blind, controlled, comparative study on intralesional 10% and 15% hypertonic saline versus intralesional sodium stibogluconate in Leishmania donovani cutaneous leishmaniasis

International Journal of Dermatology

Volumn 54, Issue 5, 2015, Pages 555-563

  Ranawaka, Ranthilaka R ^a   Weerakoon, Hema S ^a   de Silva, S H Padmal ^b  

^a Department of Dermatology   (Sri Lanka)

^b National Institute of Health Sciences   (Sri Lanka)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM CHLORIDE; STIBOGLUCONATE SODIUM; ANTIMONY GLUCONATE; ANTIPROTOZOAL AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHRONOTHERAPY; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEPIGMENTATION; DOUBLE BLIND PROCEDURE; DRUG COST; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HEALTH CARE AVAILABILITY; HUMAN; INJECTION SITE PAIN; INTENTION TO TREAT ANALYSIS; LEISHMANIA DONOVANI; LEISHMANIASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POSTINFLAMMATORY DEPIGMENTATION; POSTINFLAMMATORY HYPERPIGMENTATION; RANDOMIZED CONTROLLED TRIAL; SCAR FORMATION; SKIN LEISHMANIASIS; SKIN NECROSIS; SKIN ULCER; SURVIVAL RATE; SYSTEMIC DISEASE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; COMPARATIVE STUDY; INFANT; INTRALESIONAL DRUG ADMINISTRATION; LEISHMANIASIS, CUTANEOUS; PRESCHOOL CHILD; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIMONY SODIUM GLUCONATE; ANTIPROTOZOAL AGENTS; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFANT; INJECTIONS, INTRALESIONAL; LEISHMANIA DONOVANI; LEISHMANIASIS, CUTANEOUS; MALE; MIDDLE AGED; SALINE SOLUTION, HYPERTONIC; YOUNG ADULT;

EID: 84928362324     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/ijd.12685     Document Type: Article

References (28)

1. Castellani A. Leishmania donovani in Ceylon. J Trop Med 1904; 10: 262-263.
2. Chapman RL. Visceral leishmaniasis in an English girl. Proc R Soc Med 1973; 66: 1110.
3. Athkorala DN, Seneviratne JKK, Ihalamulla RL, et al. Locally acquired cutaneous leishmaniasis in Sri Lanka. J Trop Med Hyg 1992; 95: 432-433.
4. Karunaweera ND, Pratlong F, Siriwardane HVYD, et al. Sri Lanka cutaneous leishmaniasis is caused by Leishmania donovani zymodeme MON-37. Trans R Soc Trop Med Hyg 2003; 97: 380-381.
5. Rajapaksa US, Ihalamulla RL, Karunaweera ND. First report of mucosal tissue localization of leishmaniasis in Sri Lanka. Ceylon Med J 2005; 50: 90-91.
6. Abeygunasekara PH, Costa YJ, Seneviratne N, et al. Locally acquired visceral leishmaniasis in Sri Lanka. Ceylon Med J 2007; 52: 30-31.
7. Ranasinghe PH, Abeygunasekera PH, Athauda SB, et al. First successful in vitro culture of Leishmania sp. causing autochthonous visceral leishmaniasis in Sri Lanka. Ceylon Med J 2011; 56: 179-180.
8. Sharquie KE, Al-Talib KK, Chu AC. Intralesional therapy of cutaneous leishmaniasis with sodium stibogluconate antimony. Br J Dermatol 1988; 119: 53-57.
9. Bumb RA, Mehta RD, Ghiya BC, et al. Efficacy of short-duration (twice weekly) intralesional sodium stibogluconate in treatment of cutaneous leishmaniasis in India. Br J Dermatol 2010; 163: 854-858.
10. Aronson NE, Wortmann GW, Byrne WR, et al. A randomized controlled trial of local heat therapy versus intravenous sodium stibogluconate for the treatment of cutaneous Leishmania major infection. PLoS Negl Trop Dis 2010; 4: e628.
11. El-Sayed M, Anwar AE. Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: a comparative study. J Eur Acad Dermatol Venereol 2010; 24: 335-340.
12. Ranawaka RR, Weerakoon HS, Opathella N. Liquid nitrogen cryotherapy on L. donovani cutaneous leishmaniasis. J Dermatolog Treat 2011; 22: 241-245.
13. Mosleh IM, Geith E, Natsheh L, et al. Efficacy of a weekly cryotherapy regimen to treat Leishmania major cutaneous leishmaniasis. J Am Acad Dermatol 2008; 58: 617-624.
14. Sharquie KE. A new intralesional therapy of cutaneous leishmaniasis with hypertonic sodium chloride solution. J Dermatol 1995; 22: 732-737.
15. Sharquie KE, Najim RA, Farjou IB. A comparative controlled trial of intralesionally administered zinc sulfate, hypertonic sodium chloride and pentavalent antimony compound against acute cutaneous leishmaniasis. Clin Exp Dermatol 1997; 22: 169-173.
16. Ranawaka RR, Weerakoon HS. Randomized, double blind, comparative clinical trial on efficacy and safety of intralesional sodium stibogluconate and intralesional 7% hypertonic sodium chloride against cutaneous leishmaniasis caused by L. donovani. J Dermatolog Treat 2010; 21: 286-293.
17. Schulz KF, Grimes DA. Multiplicity in randomized trials II: subgroup and interim analyses. Lancet 2005; 365: 1657-1661.
18. Rajapaksa US, Ihalamulla RL, Udagedera C, et al. Cutaneous leishmaniasis in southern Sri Lanka. Trans R Soc Trop Med Hyg 2007; 101: 799-803.
19. Ranawaka RR, Weerakoon HS, Opathella N, et al. Leishmaniasis in the North Central Province Sri Lanka - epidemiology and therapeutic response. Sri Lanka J Dermatol 2010; 14: 4-8.
20. World Health Organization. The Leishmaniases: Report of a WHO Expert Committee. Technical Report Series WHO701. Geneva: WHO, 1984.
21. Faris RM, Jarallah JS, Khoja TA, et al. Intralesional treatment of cutaneous leishmaniasis with sodium stibogluconate antimony. Int J Dermatol 1993; 32: 610-612.
22. Tallab TM, Bahamdam KA, Mirdad S, et al. Cutaneous leishmaniasis: schedules for intralesional treatment with sodium stibogluconate. Int J Dermatol 1996; 35: 594-597.
23. Sundar S. Drug resistance in Indian visceral leishmaniasis. Trop Med Int Health 2001; 6: 849-854.
24. Gurgen J, Hogan D, Grace E, et al. Nitazoxanide in the treatment of chronic cutaneous leishmaniasis resistant to traditional sodium stibogluconate. J Am Acad Dermatol 2011; 64: 202-203.
25. Dutra RA, Dutra LF, Reis Mde O, et al. Splenectomy in a patient with treatment-resistant visceral leishmaniasis: a case report. Rev Soc Bras Med Trop 2012; 45: 130-131.
26. Aït-Oudhia K, Gazanion E, Vergnes B, et al. Leishmania antimony resistance: what we know what we can learn from the field. Parasitol Res 2011; 109: 1225-1232.
27. Surendran SN, Kajatheepan A, Ramasamy R. Socio-environmental factors and sandfly prevalence in Delft Island, Sri Lanka: implications for leishmaniasis vector control. J Vector Borne Dis 2007; 44: 65-68.
28. Nawaratna SS, Weilgama DJ, Rajapakska K. Cutaneous leishmaniasis in Sri Lanka: a study of possible animal reservoirs. Int J Infect Dis 2009; 13: 513-517.